Delivery Order SPE2DB24D2100-SPE2DB24FBCKS
Award Date
7/15/24
Potential Completion Date
8/5/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. The $7,792.08 firm fixed price contract was awarded on July 8, 2024 by the Defense Logistics Agency (DLA), with a completion date of July 29, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product IBRANCE 125 MG TABLET 7S to the Defense Logistics Agency (DLA), a defense agency. The $15,584.16 fixed-price delivery order has a completion date of June 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, including the IBRANCE 100 MG TABLET 7S, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $7,796.30, is a Firm Fixed Price Delivery Order with a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 Firm Fixed Price Delivery Order contract, which does not have a set-aside designation, is for the supply of IBRANCE 125 MG TABLET 7S. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, including the medication IBRANCE 125 MG TABLET 7S, to the Defense Logistics Agency (DLA). The $7,792.08 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,236.16 firm fixed-price delivery order is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,792.08 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. The contract has an ultimate completion date of July 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG TABLET 7S. The contract, valued at $23,380.46, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. The contract is a delivery order type with a firm fixed-price pricing structure. It was awarded on September 16, 2024 and has an ultimate completion date of October 7, 2024. Amerisourcebergen, a major...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG TABLET 7S. The contract has a ceiling value of $7,792.08 and an ultimate completion date of August 1, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,484.74 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a specialty medication. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...